Abstract

Dr. Amit Kumar*, Dr. Varun Kumar, Dr. Himanshu Saini

ABSTRACT

Background: Bhasma — the incinerated herbo-metallic preparations of Rasa Shastra — are ingested orally and must, by anatomical necessity, traverse the human gastrointestinal tract before exerting systemic therapeutic effects. The gut microbiome, a dynamic ecosystem of trillions of microorganisms, occupies precisely this transit zone and is now recognised as a pivotal determinant of drug bioavailability, immune regulation, and intestinal homeostasis. Despite this fundamental anatomical overlap, no systematic investigation or conceptual framework has been published addressing the interaction between Bhasma preparations and the gut microbial ecosystem. Objective: The present review aims to construct a hypothesis-driven conceptual framework — drawing from classical Ayurvedic pharmacology, modern microbiome science, heavy metal–microbiota interaction research, and nanomedicine — to explore plausible mechanisms through which Bhasma preparations may influence gut microbial ecology, and conversely, how the microbiome may shape Bhasma bioavailability and therapeutic outcomes. Methods: Classical Ayurvedic texts including Charaka Samhita, Sushruta Samhita, Ashtanga Hridayam, Rasa Tarangini, and Rasa Ratna Samuccaya were reviewed alongside contemporary literature from PubMed, Google Scholar, DHARA, Frontiers in Nutrition, and Nature journals on gut microbiome, heavy metal–microbiota interactions, and nanomedicine. Results: Classical Ayurveda provides implicit recognition of gut microbial ecosystems through the concept of Agni and Grahani physiology, though without explicit microbial nomenclature. Contemporary science demonstrates that ingested metals — including mercury, iron, copper, zinc, silver and arsenic — exert profound, concentration-dependent, and speciation-dependent effects on gut microbial composition. Classical Shodhana and Marana processes transform these metals into nanoparticulate, organo-metallic complexes that may interact with the microbiome fundamentally differently than their raw or ionised counterparts. Five mechanistic pathways of potential Bhasma–microbiome interaction are proposed. Conclusion: The Bhasma–gut microbiome interface represents a scientifically compelling, clinically significant, and entirely uncharted domain of inquiry. The present article offers a research framework and calls for systematic experimental investigation to explore this novel frontier.